Los puntos clave no están disponibles para este artículo en este momento.
Allogeneic HSCT recipients have an increased risk of BCC, SCC, and MM. Total-body irradiation was a major determinant for BCC. Our findings indicate the relevance of dermatologic follow-up in HSCT recipients.
Omland et al. (Sat,) studied this question.